GPCRs are recognized as highly druggable receptors with untapped potential in fibrosis therapy. At Telescope Therapeutics, our discovery platform includes three powerful aspects:
A world-class team with deep expertise in GPCRs, enabling us to rediscover and target underexplored GPCRs or location bias for established targets
Leveraging our core strengths in cardiology and stem cell biology, we deploy human iPSC-derived models of fibrosis
Integrating FRET-based biosensors into our platforms allows real-time tracking of critical receptor-dependent signaling events across the cell.